Microbial Drug Resistance focuses on the growing global threat of antimicrobial resistance. This peer-reviewed journal provides a comprehensive forum for disseminating cutting-edge research on mechanisms of resistance, the epidemiology of resistant organisms, and strategies to combat drug resistance. The journal covers both basic science and clinical aspects of resistance in bacteria, fungi, viruses, and parasites.
Core areas of focus include clinical microbiology, infectious diseases, vaccinology, and epidemiology. It also emphasizes molecular mechanisms research on bone and bone-related diseases, autoimmune hepatitis, biliary diseases, and viral hepatitis. Its target audience includes microbiologists, infectious disease specialists, pharmacists, and public health officials.
Microbial Drug Resistance promotes innovative research aimed at developing new antimicrobial agents, improving diagnostic techniques, and implementing effective infection control measures. By fostering collaboration and knowledge sharing, the journal strives to mitigate the impact of drug-resistant microbes on global health.